We believe in the simple life
This cycling approach serves multiple purposes: it prevents potential receptor desensitization, maintains copper homeostasis, and allows assessment of results before continuing
As of July 26, 2026, 21 CFR 216.23 lists six substances that can be used through this pathway: Brilliant Blue G, cantharidin for topical use only, diphenylcyclopropenone for topical use only, N-acetyl-D-glucosamine for topical use only, squaric acid dibutyl ester for topical use only, and thymol iodide for topical use only
Patients taking prescription SNRIs should treat BPC-157 as an uncharacterized compound when evaluating polypharmacy risk
10mg, 50mg, 100mg, 1g, 10g, 50g per package, with ice packs
Until we have better science, better standardization of what we're getting